The New York Times defended its reporting on Elon Musk‘s drug use, after he claimed that the publication was “lying” in its article that claimed he was, amongst different issues, “taking so much ketamine, a powerful anesthetic, that it was affecting his bladder, a known effect of chronic use. He took Ecstasy and psychedelic mushrooms.”
Over the weekend, Musk attacked the report from Kristen Grind and Megan Twohey, writing on X that “to be clear, I am NOT taking drugs! The New York Times was lying their ass off. I tried *prescription* ketamine a few years ago and said so on 𝕏, so this not even news. It helps for getting out of dark mental holes, but haven’t taken it since then.”
The Times responded with a press release, “Kirsten Grind and Megan Twohey’s thoroughly sourced report provides an important and fair look into Musk’s drug use and family conflicts. They interviewed a dozen people who have known or worked with him, and saw private text messages, legal documents and photographic evidence.”
They additionally addressed any notion that Musk was not given a chance to reply. “Elon Musk is just lashing out because he doesn’t like our article. We provided Musk with multiple opportunities to reply or rebut this reporting before publication and he declined, opting instead to try to distract with a social post and no evidence.”
The report, revealed on Friday, additionally claimed that Musk traveled with a medicine field that held about 20 tablets,. The Times famous that it was unclear if Musk “was taking drugs when he became a fixture at the White House this year and was handed the power to slash the federal bureaucracy.” They did check with his erratic habits when he served in his authorities position.
Musk appeared with Trump on Friday in an Oval Office press convention, form of a swan tune because the billionaire’s official authorities service got here to an finish.
Fox News’ Peter Doocy tried to ask Musk in regards to the report, however Musk reduce him off and as a substitute accused the Times of being discredited in its Pulitzer Prize profitable protection of the investigation into Russian interference within the 2016 election and attainable coordination with the Trump marketing campaign.